205 related articles for article (PubMed ID: 437435)
21. The septic burned patient: a model for studying the role of complement and immunoglobulins in opsonization of opportunist micro-organisms.
Bjornson AB; Altemeier WA; Bjornson HS
Ann Surg; 1979 Apr; 189(4):515-27. PubMed ID: 109057
[TBL] [Abstract][Full Text] [Related]
22. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
23. [Determination of the alternative complement pathway in patients with amebic liver abscess].
Capin MR; Jiménez M; Zamacona G; Ortíz-Ortíz L
Arch Invest Med (Mex); 1978; 9 Suppl 1():297-302. PubMed ID: 697476
[TBL] [Abstract][Full Text] [Related]
24. [C3, C4, factor B components in septic states].
Laurent P; Goudot B; Grozel JM
Nouv Presse Med; 1978 Jul 1-8; 7(27):2406. PubMed ID: 673827
[No Abstract] [Full Text] [Related]
25. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
[No Abstract] [Full Text] [Related]
26. Alternate and classical pathway components of complement in the normal cornea.
Mondino BJ; Ratajczak HV; Goldberg DB; Schanzlin DJ; Brown SI
Arch Ophthalmol; 1980 Feb; 98(2):346-9. PubMed ID: 6766301
[TBL] [Abstract][Full Text] [Related]
27. Alternative pathway of complement in sickle cell disease.
Strauss RG; Asbrock T; Forristal J; West CD
Pediatr Res; 1977 Apr; 11(4):285-9. PubMed ID: 846782
[TBL] [Abstract][Full Text] [Related]
28. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
29. Significance of serum complement levels in patients with gastrointestinal disease.
Ross IN; Thompson RA; Montgomery RD; Asquith P
J Clin Pathol; 1979 Aug; 32(8):798-801. PubMed ID: 512040
[TBL] [Abstract][Full Text] [Related]
30. [Measurement of serum complement hemolytic activity--effect of separation and storage conditions of the serum and reference values].
Okumura N; Kameko M; Kanai M
Rinsho Byori; 1983 Nov; 31(11):1219-23. PubMed ID: 6672294
[No Abstract] [Full Text] [Related]
31. [The relevance of serum-complement factors in chronic obstructive pulmonary disease (author's transl)].
Lanzer G; Borkenstein J
Acta Med Austriaca; 1981; 8(3):93-8. PubMed ID: 6911988
[TBL] [Abstract][Full Text] [Related]
32. Activation of the alternative complement pathway in ascitic fluid during spontaneous bacterial peritonitis.
Fromkes JJ; Thomas FB; Kraut EH
J Clin Gastroenterol; 1982 Aug; 4(4):347-50. PubMed ID: 6749961
[TBL] [Abstract][Full Text] [Related]
33. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
[TBL] [Abstract][Full Text] [Related]
34. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
Velosa J; Miller K; Michael AF
Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
[TBL] [Abstract][Full Text] [Related]
35. Circulating immune complexes and complement levels in hemophilic children.
Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
[TBL] [Abstract][Full Text] [Related]
36. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
37. Influence of age and sex on serum complement components in children.
Roach B; Kim Y; Jerome E; Michael AF
Am J Dis Child; 1981 Oct; 135(10):918-20. PubMed ID: 6975036
[TBL] [Abstract][Full Text] [Related]
38. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
[TBL] [Abstract][Full Text] [Related]
39. Prevention of immune precipitation by purified components of the alternative pathway.
Naama JK; Holme E; Hamilton E; Whaley K
Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
[TBL] [Abstract][Full Text] [Related]
40. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
Fearon DT; Austen KF; Ruddy S
Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
